| Literature DB >> 8612228 |
M A Barry1, W J Dower, S A Johnston.
Abstract
Ideal gene therapy vectors would be delivered intravenously to transfect only specific cells. Existing vectors only transfect cells in vivo in a manner determined by blood flow and the site of introduction. As a general and systematic approach for generating cell-targeting ligands for gene therapy vectors, we have used peptide-presenting phage libraries to select peptides that bind and enter several different cell types. Because of their small size, cell-binding peptides such as these could be incorporated into biological or physical gene therapy vectors. In addition, peptide-presenting phage themselves may also be candidates for gene therapy vectors.Mesh:
Substances:
Year: 1996 PMID: 8612228 DOI: 10.1038/nm0396-299
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440